Page 22 - Bridge Access Program News Today

With the end of the public health emergency the COVID-19 vaccine is now commercial and can cost between $115 and $128 per dose.

On Tuesday, the U.S. FDA authorized Novavax’s updated COVID-19 vaccine for use in people aged 12 years and older. This means people will now have the choice of a protein-based non-MRNA option to help protect themselves and their families against the XBB variant this fall. Its vaccine is the only protein-based, non-mRNA updated COVID-19 vaccine available.

If your insurance does not include CVS or Walgreens as an "in-network pharmacy," you may be charged up to $200.

With the end of the public health emergency the COVID-19 vaccine is now commercial and can cost between $115 and $128 per dose.

DENTAL DAY OF CARE: Braydich Dental in Hubbard is hosting its annual Smiles From the Heart event, a free day of dental care to provide essential oral health ser

Some 11.6 percent of coronavirus tests in the U.S. were positive in the week through September 23, according to the latest CDC data.

Health officials see Novavax’s protein-based vaccine as a valuable alternative for people who don’t want to take messenger RNA shots from Pfizer and...

Health officials see Novavax's protein-based vaccine as a valuable alternative for people who don't want to take messenger RNA shots from Pfizer and Moderna.

The federal Centers for Disease Control and prevention recommends everyone 6 months and older get an updated COVID-19 vaccine to protect against the potentially serious outcomes of COVID-19 illness this

With the end of the public health emergency the COVID-19 vaccine is now commercial and can cost between $115 and $128 per dose.